Guaifenesin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Condition:   Healthy Subjects Interventions:   Drug: Vicks Cough Syrup for Chesty Coughs;   Drug: Robitussin Extra Strength Chest Congestion;   Drug: Organ-I- NR tablet Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Condition:   Healthy Subjects Interventions:   Drug: Vicks Cough Syrup for Chesty Coughs;   Drug: Robitussin Extra Strength Chest Congestion;   Drug: Organ-I- NR tablet Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Condition:   Healthy Subjects Interventions:   Drug: Vicks Cough Syrup for Chesty Coughs;   Drug: Robitussin Extra Strength Chest Congestion;   Drug: Organ-I- NR tablet Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition:   Healthy Subjects Interventions:   Drug: Mucinex® SE;   Drug: Vicks Cough Syrup for Chesty Coughs Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2018 Category: Research Source Type: clinical trials

Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate
Condition:   Healthy Subjects Interventions:   Drug: Humibid®;   Drug: Hydrocodone Bitartrate;   Drug: Humibid® and Hydrocodone Bitartrate tablet Sponsor:   Reckitt Benckiser LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2018 Category: Research Source Type: clinical trials

Mucinex ® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h
Condition:   Healthy Subjects Intervention:   Drug: Mucinex® Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2018 Category: Research Source Type: clinical trials

Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate
Condition:   Healthy Subjects Interventions:   Drug: Humibid®;   Drug: Hydrocodone Bitartrate;   Drug: Humibid® and Hydrocodone Bitartrate tablet Sponsor:   Reckitt Benckiser LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2018 Category: Research Source Type: clinical trials

Mucinex ® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h
Condition:   Healthy Subjects Intervention:   Drug: Mucinex® Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2018 Category: Research Source Type: clinical trials

Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate
Condition:   Healthy Subjects Interventions:   Drug: Humibid®;   Drug: Hydrocodone Bitartrate;   Drug: Humibid® and Hydrocodone Bitartrate tablet Sponsor:   Reckitt Benckiser LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2018 Category: Research Source Type: clinical trials

Mucinex ® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h
Condition:   Healthy Subjects Intervention:   Drug: Mucinex® Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2018 Category: Research Source Type: clinical trials

Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate
Condition:   Healthy Subjects Interventions:   Drug: Humibid®;   Drug: Hydrocodone Bitartrate;   Drug: Humibid® and Hydrocodone Bitartrate tablet Sponsor:   Reckitt Benckiser LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2018 Category: Research Source Type: clinical trials

Mucinex ® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h
Condition:   Healthy Subjects Intervention:   Drug: Mucinex® Sponsor:   Reckitt Benckiser Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2018 Category: Research Source Type: clinical trials